Gómez-Rial Jose, Rivero-Calle Irene, Salas Antonio, Martinón-Torres Federico
Genetics, Vaccines, Infectious Diseases Research Group (GENVIP), Health Research Institute Santiago (IDIS), Hospital Clínico Universitario Santiago de Compostela (SERGAS), Galicia 15706, Spain.
Immunology Laboratory, Clinical Laboratory, Hospital Clínico Universitario Santiago de Compostela (SERGAS), Galicia 15706, Spain.
Infect Drug Resist. 2020 Jul 22;13:2485-2493. doi: 10.2147/IDR.S258639. eCollection 2020.
Emerging studies from SARS-CoV-2-infected patients indicate a preponderant role of monocytes/macrophages in the pathogenesis of this viral infection, in a similar way to that previously observed in other coronavirus outbreaks (SARS and MERS). The clinical presentation of severe patients resembles viral-associated hemophagocytic syndrome, a rare condition previously seen during lethal influenza pandemics and during previous SARS and MERS coronavirus outbreaks. SARS-CoV-2 infection triggers an over-exuberant inflammatory response due to the development of a cytokine storm and the depletion of the adaptative immune compartment, which may prelude sepsis in many cases. The present review summarizes past evidence on the role of monocytes/macrophages in previous coronavirus outbreaks and the emerging knowledge on their role in COVID-19 pathogenesis. Treatment strategies incorporating the blockade of migration and differentiation of monocyte-macrophage, such as granulocyte macrophage-colony stimulating factor inhibitors, might enhance the promising results seen so far with selective cytokine blockade.
来自感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)患者的新研究表明,单核细胞/巨噬细胞在这种病毒感染的发病机制中起主要作用,这与之前在其他冠状病毒爆发(非典和中东呼吸综合征)中观察到的情况类似。重症患者的临床表现类似于病毒相关噬血细胞综合征,这是一种罕见病症,以前在致命性流感大流行以及之前的非典和中东呼吸综合征冠状病毒爆发期间出现过。由于细胞因子风暴的发展和适应性免疫区室的耗竭,SARS-CoV-2感染引发过度旺盛的炎症反应,这在许多情况下可能是败血症的前奏。本综述总结了过去关于单核细胞/巨噬细胞在以往冠状病毒爆发中作用的证据,以及它们在2019冠状病毒病发病机制中作用的新认识。纳入阻断单核细胞-巨噬细胞迁移和分化的治疗策略,如粒细胞巨噬细胞集落刺激因子抑制剂,可能会增强迄今为止选择性细胞因子阻断所取得的良好效果。